ES2104522T1 - Un nuevo sistema de suministro de farmacos. - Google Patents

Un nuevo sistema de suministro de farmacos.

Info

Publication number
ES2104522T1
ES2104522T1 ES95924940T ES95924940T ES2104522T1 ES 2104522 T1 ES2104522 T1 ES 2104522T1 ES 95924940 T ES95924940 T ES 95924940T ES 95924940 T ES95924940 T ES 95924940T ES 2104522 T1 ES2104522 T1 ES 2104522T1
Authority
ES
Spain
Prior art keywords
pct
date jan
sec
supply system
layers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES95924940T
Other languages
English (en)
Other versions
ES2104522T3 (es
Inventor
Paolo Alberto Veronesi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Therapicon SRL
Original Assignee
Therapicon SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therapicon SRL filed Critical Therapicon SRL
Publication of ES2104522T1 publication Critical patent/ES2104522T1/es
Application granted granted Critical
Publication of ES2104522T3 publication Critical patent/ES2104522T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

PRODUCTO FARMACEUTICO EN FORMA DE DOSIFICACION UNITARIA Y SISTEMA DE SUMINISTRO DE MEDICAMENTOS DE DOSIFICACION UNITARIA QUE INCLUYE UNA CAPSULA O CONTENEDOR DE CAPA MULTIPLE QUE TIENE DOS O MAS CAPAS MATERIALES , TENIENDO LA CAPA EXTERIOR UN CARACTER HIDROFILICO Y LA INTERIOR UN CARACTER HIDROFOBICO, DE FORMA QUE EXISTEN UNA O MAS SUSTANCIAS MEDICAMENTOSAS DE CARACTER HIDROFOBICOS EN CONTACTO CON LA CAPA INTERIOR.
ES95924940T 1994-07-11 1995-06-24 Nuevo sistema de administracion de medicamento. Expired - Lifetime ES2104522T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9413951A GB2290965A (en) 1994-07-11 1994-07-11 Multiple layer capsules for drugs

Publications (2)

Publication Number Publication Date
ES2104522T1 true ES2104522T1 (es) 1997-10-16
ES2104522T3 ES2104522T3 (es) 1999-03-16

Family

ID=10758141

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95924940T Expired - Lifetime ES2104522T3 (es) 1994-07-11 1995-06-24 Nuevo sistema de administracion de medicamento.

Country Status (12)

Country Link
US (1) US5814338A (es)
EP (1) EP0769938B1 (es)
JP (1) JPH10502376A (es)
KR (1) KR100381208B1 (es)
AT (1) ATE172638T1 (es)
AU (1) AU707076B2 (es)
CA (1) CA2194890A1 (es)
DE (2) DE769938T1 (es)
ES (1) ES2104522T3 (es)
GB (1) GB2290965A (es)
WO (1) WO1996001612A1 (es)
ZA (1) ZA955741B (es)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9426079D0 (en) * 1994-12-23 1995-02-22 Orion Yhtymae Oy A gelatine capsule
US5708017A (en) * 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
KR19990022443A (ko) * 1995-06-07 1999-03-25 조셉 이. 미첼 충진물질에 의한 침투를 막는 외피를 갖는 연질 젤라틴 캡슐을제조하기 위한 방법 및 조성물
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
IT1293835B1 (it) * 1997-08-08 1999-03-10 Foscama Biomed Chim Farma Composizioni farmaceutiche orali in forma solida a cessione modulata contenenti nicorandil e procedimento per la loro preparazione
WO1999022719A1 (fr) * 1997-10-30 1999-05-14 Morishita Jintan Co., Ltd. Preparation de capsule contenant un acide gras insature ou un derive de celui-ci, et procede de fabrication
NL1009107C2 (nl) * 1997-11-12 1999-06-15 Banner Pharmacaps Inc Gelatine-uitspreidende doos met meervoudige, aanpasbare poortklep en meerlagig zacht gel.
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
EE04576B1 (et) * 1997-12-08 2006-02-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Suposiit happes ebapüsivate toimeainete tarbeks, selle valmistamismeetod, toimeaineühik ja selle valmistamismeetod ning preparaat
DE19801811B4 (de) * 1998-01-19 2004-12-23 Stada Arzneimittel Ag Pharmazeutische Zubereitung zur oralen Verabreichung
DE19814257A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Brauseformulierungen
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
JP4854115B2 (ja) * 1999-03-12 2012-01-18 エイシカ ファーマシューティカルス リミテッド 無水パロキセチン用安定製剤形
FR2793688B1 (fr) 1999-05-21 2003-06-13 Ethypharm Lab Prod Ethiques Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
US6423746B1 (en) * 1999-07-03 2002-07-23 The William M. Yarbrough Foundation Urushiol induced contact dermatitis and method of use
PT1108431E (pt) * 1999-12-16 2003-08-29 Medinfar Produtos Farmaceutico Preparacoes farmaceuticas gastro-resistentes multiunitarias contendo piroxicam
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
GB2398499B (en) * 2000-02-16 2004-11-24 Bioprogress Technology Ltd Two layer capsules
US6365181B1 (en) 2000-04-20 2002-04-02 Gattefosse Corporation Thixatropic gelatin carrier composition
US6306435B1 (en) 2000-06-26 2001-10-23 Yung Shin Pharmaceutical Industrial Co. Ltd. Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same
ITMI20011401A1 (it) * 2001-07-02 2003-01-02 Altergon Sa Formulazioni farmaceutiche per ormoni tiroidei
AR034813A1 (es) * 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
JP2005521662A (ja) * 2002-01-25 2005-07-21 サンタラス インコーポレイティッド プロトンポンプ阻害剤の経粘膜送達
GB0203296D0 (en) 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
US8168170B2 (en) 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
MY148805A (en) * 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
TWI319713B (en) * 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
JP2006518751A (ja) * 2003-02-20 2006-08-17 サンタラス インコーポレイティッド 胃酸の急速かつ持続的な抑制のための新規製剤、オメプラゾール制酸剤複合体−即時放出物
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US7247010B2 (en) * 2003-10-01 2007-07-24 Technophar Equipment & Service Limited Servo control for capsule making machine
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
US20050118124A1 (en) * 2003-12-01 2005-06-02 Reinhart Gale M. Compositions for treating keratinous surfaces
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2006050425A2 (en) * 2004-11-02 2006-05-11 Machine Solutions, Inc. Stent sheathing technology
AU2006253007B2 (en) 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
EP2270131A1 (en) 2005-05-31 2011-01-05 The Iams Company Feline probiotic lactobacilli
CN101242856A (zh) 2005-09-09 2008-08-13 莱博法姆公司 持续药物释放的组合物
US8298602B2 (en) * 2005-10-11 2012-10-30 Purecircle Sdn Bhd Process for manufacturing a sweetener and use thereof
US20070203040A1 (en) * 2006-02-24 2007-08-30 Harry Reicherz Bar soap
US20100297226A1 (en) * 2006-06-01 2010-11-25 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
JP5233108B2 (ja) * 2006-10-24 2013-07-10 ゼリア新薬工業株式会社 ニザチジン含有医薬組成物
PL2124966T3 (pl) 2007-02-01 2016-01-29 Iams Europe B V Sposób zmniejszania reakcji zapalnej i stresu u ssaków za pomocą antymetabolitów glukozy, awokado lub ekstraktów awokado
CA2623684A1 (en) * 2007-03-06 2008-09-06 X.O. Industries Inc. Spreader box apparatus and method of forming bi-laminar paintball shell material and paintballs for use with paintball gun
WO2008112227A1 (en) * 2007-03-12 2008-09-18 Reliant Pharmaceuticals, Inc. Treatment with nicorandil and omega-3 fatty acids, and a combination product thereof
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
FR2936952A1 (fr) * 2008-10-09 2010-04-16 Monique Bellec Administration par voie orale de medicaments et complements nutritionnels
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
EP2493478B8 (en) * 2009-10-29 2018-03-28 Acasti Pharma, Inc. Concentrated therapeutic phospholipid compositions
ES2364011B1 (es) 2009-11-20 2013-01-24 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados para el tratamiento de enfermedades cardiovasculares.
ES2363964B1 (es) 2009-11-20 2012-08-22 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados.
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
KR20190038610A (ko) 2016-08-05 2019-04-08 타우루스 디벨롭먼트 컴퍼니 엘엘씨 실온 안정성 경구 칼시토닌 제제
US11298336B2 (en) 2019-05-30 2022-04-12 Soluble Technologies, Inc. Water soluble formulation
US11786475B2 (en) 2020-07-22 2023-10-17 Soluble Technologies Inc. Film-based dosage form
US20230285245A1 (en) * 2022-01-24 2023-09-14 Ofd Biopharma, Llc Methods, systems, and materials for making unit dosage forms

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH476499A (de) * 1964-12-31 1969-08-15 Ciba Geigy Mischung zum Überziehen von Rektal-Kapseln
YU36434B (en) * 1969-05-14 1984-02-29 Sanol Arznei Schwarz Gmbh Process for obtaining gelation capsules filled with the active substance resistant to gastric juice and dissolvable in the small intestine
DE2340060A1 (de) * 1973-08-08 1975-02-20 Scherer Gmbh R P Magensaftresistente gelatinekapseln und verfahren zu deren herstellung
DE3437599A1 (de) * 1984-10-13 1986-04-17 Dolorgiet GmbH & Co KG, 5205 St Augustin Ibuprofen enthaltende weichgelatinekapseln und verfahren zu ihrer herstellung
US4816259A (en) * 1987-02-12 1989-03-28 Chase Chemical Company, L.P. Process for coating gelatin capsules
JPH01232963A (ja) * 1988-03-14 1989-09-18 Arimento Kogyo Kk 重層軟カプセルの製造方法
DE3818022C2 (de) * 1988-05-24 1994-04-28 Guenter Stephan Weichgelatinekapsel
DE3927113C2 (de) * 1989-08-17 1993-11-25 Dolorgiet Gmbh & Co Kg Mittel zur Behandlung von schweren Schmerzzuständen und Verfahren zu ihrer Herstellung
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form

Also Published As

Publication number Publication date
KR100381208B1 (ko) 2003-07-18
DE69505671T2 (de) 1999-06-10
AU707076B2 (en) 1999-07-01
DE69505671D1 (de) 1998-12-03
JPH10502376A (ja) 1998-03-03
DE769938T1 (de) 1997-09-11
AU2925295A (en) 1996-02-09
ES2104522T3 (es) 1999-03-16
EP0769938A1 (en) 1997-05-02
WO1996001612A1 (en) 1996-01-25
GB9413951D0 (en) 1994-08-31
GB2290965A (en) 1996-01-17
ATE172638T1 (de) 1998-11-15
EP0769938B1 (en) 1998-10-28
US5814338A (en) 1998-09-29
ZA955741B (en) 1997-01-07
CA2194890A1 (en) 1996-01-25
KR970704427A (ko) 1997-09-06

Similar Documents

Publication Publication Date Title
ES2104522T1 (es) Un nuevo sistema de suministro de farmacos.
DE19882362T1 (de) Mikropartikel, geeignet als Ultraschallkontrastmittel und zum Transport von Arzneimitteln in den Blutstrom
PT1117386E (pt) Administracao enterica e colonica utilizando capsulas de hpmc
PL325774A1 (en) Drug delivery system for two or more active substances
CY1105026T1 (el) Συστημα χορηγησεως φαρμακου : συνθεση δια λιπο-διαλυτα φαρμακα
PT693924E (pt) Processos para administracao (in vivo) de substancias biologicas e composicoes utilizadas nestes processos
HU76547A2 (en) Process for producing pharmaceutical compositions containing agent in polymer-matrix and in solid solution form and these medicaments
KR900011486A (ko) 하이드로겔에 의해 작동되는 분배장치
NO963202L (no) Misbruksresistente tabletter
MY112915A (en) Multiple unit tableted dosage form 1
ATE232100T1 (de) Gegen magensaft geschützte omeprazol- mikrogranülen, herstellungsverfahren und pharmazeutische zubereitungen
GR3033301T3 (en) Medicament form for the delivery of active substances to wounds
AU2155199A (en) Microparticles for drug delivery across mucosa and the blood-brain barrier
DE69519685D1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
ZA200001852B (en) Sustained release information.
AR011437A1 (es) Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento.
DE59708495D1 (de) Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung
ATE256134T1 (de) Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
SE9503620D0 (sv) Användning av proteinet S-100b i läkemedel samt läkemedel innehållande proteinet S-100b
FR2751967B1 (fr) Agents antipaludeens et antibabesioses et compositions pharmaceutiques les contenant
BR9801839A (pt) Medicamento analgésico e aplicação de (+) -0-demetiltramadol.
TH57760B (th) การลำเลียงยาสู่ลำไส้เล็กและลำไส้ใหญ่โดยใช้แคปซูลชนิด hpmc
MX9803093A (es) Suministro de polipeptidos biologicamente activos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 769938

Country of ref document: ES